Which has grown faster, IQV or MRNA?

Over the past five years, IQV grew revenue faster — IQV at a 6.72% CAGR versus MRNA at -2.60%.

Is IQV or MRNA more profitable?

IQV runs the higher net margin — IQV at 8.33% versus MRNA at -143.55%.

Which has been the better investment, IQV or MRNA?

Over the past 5-year, IQV delivered the higher annualized total return — IQV at 10.41% versus MRNA at -21.13%. Past performance doesn't predict future results.

IQVIA Holdings Inc. (IQV) vs Moderna, Inc. (MRNA)

IQV leads on 8 of 10 compared metrics.

A side-by-side comparison of IQVIA Holdings Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 18, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — IQV vs MRNA

growth of $100 · last 8y

IQV +44.7%MRNA +232.3%MRNA compounded faster

IQV MRNA

IQV vs MRNA: by the numbers

•IQV is the larger company ($28.48B vs $24.52B market cap).
•IQV is profitable (8.33% net margin) while MRNA runs a net loss (-143.55%).
•IQV grew revenue faster over the past five years (6.72% vs -2.60% CAGR).

Which is better, IQV or MRNA?

Metric tally: IQV 8 · MRNA 2

It depends on what you're optimizing for:

GrowthIQV(faster 5Y revenue CAGR)

QualityIQV(higher ROIC)

Metrics side by side

Valuation

Metric	IQV	MRNA
P/E ratio	21.15	—
Forward P/E	12.05	—
P/S ratio	1.74●	10.97
P/B ratio	4.66	3.30●
PEG ratio	6.34	—
EV / EBITDA	12.25	—
FCF yield	8.78%	—

Profitability

Metric	IQV	MRNA
Gross margin	26.11%●	-13.89%
Operating margin	13.86%●	-153.35%
Net margin	8.33%●	-143.55%
ROE	22.26%●	-43.12%
ROIC	8.23%●	-29.70%

Growth (annualized)

Metric	IQV	MRNA
Revenue CAGR (5Y)	6.72%●	-2.60%
EPS CAGR (5Y)	40.21%	—
FCF CAGR (5Y)	4.53%	126.92%●
Total return CAGR (5Y)	-7.07%●	-21.13%

Frequently asked

Which is better, IQV or MRNA?: It depends on your goal. growth: IQV (faster 5Y revenue CAGR); quality: IQV (higher ROIC). Across all compared metrics, IQV leads 8 to 2.
Which has grown faster, IQV or MRNA?: Over the past five years, IQV grew revenue faster — IQV at a 6.72% CAGR versus MRNA at -2.60%.
Is IQV or MRNA more profitable?: IQV runs the higher net margin — IQV at 8.33% versus MRNA at -143.55%.
Which has been the better investment, IQV or MRNA?: Over the past 5-year, IQV delivered the higher annualized total return — IQV at 10.41% versus MRNA at -21.13%. Past performance doesn't predict future results.

Go deeper

Full IQV analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

IQVIA P/E ratio Moderna P/E ratio IQVIA dividend yield Moderna dividend yield IQVIA ROE Moderna ROE IQVIA operating margin Moderna operating margin IQVIA revenue growth Moderna revenue growth IQVIA free cash flow Moderna free cash flow

IQVIA & Moderna appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 18, 2026.